Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health | MicrobiomeTrials← Back to trialsNCT04573062
Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health
RecruitingOBSERVATIONAL
Trial Details
Start: 2022-01-02Est. Completion: 2027-12-31
Enrollment target: 1,590 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Anogenital HerpesCOVID-19Herpes Labialis
Background:
\- Viral infections are an important cause of illness and death in hospitalized patients as well as outpati…
Bethesda, United States
COVID-19ARDS
COVID-19 patients who develop severe disease often develop acute respiratory distress syndrome (ARDS) as a result of a d…
Fresno, United StatesCompleted Jul 22, 2024
Completed
SepsisPneumoniaLower Resp Tract InfectionCovid19
An adaptive platform trial to compare effectiveness of different care models to prevent readmissions for patients hospit…
Pittsburgh, United StatesCompleted Dec 15, 2024